Abstract
The 2013–2016 West African Ebola virus (EBOV) disease (EVD) outbreak was the largest in history with 28 616 cases and 11 310 deaths in the highest transmission countries (Sierra Leone, Guinea, and Liberia).1 Reports of uveitis have emerged in EVD survivors.2, 3 We discuss clinical features, multimodality imaging, and long-term management of aggressive, sight-threatening panuveitis in an EVD survivor, providing insight into the pathogenesis of this condition.
Original language | English |
---|---|
Pages (from-to) | 2626-2628.e2 |
Number of pages | 3 |
Journal | Ophthalmology |
Volume | 123 |
Issue number | 12 |
DOIs | |
Publication status | Published - 1 Dec 2016 |
Keywords
- vitreous inflammation
- Ebola
- heterochromia
- conjunctival swab